Treatment of Parkinson's disease with controlled-release Carbidopa L-DOPA

被引：0
|
作者：
Pahwa, R
Koller, WC
机构：
来源：
PARKINSON'S DISEASE | 1996年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：487 / 491
页数：5
相关论文
共 50 条
  • [1] Entacapone increases the bioavailability of controlled-release L-dopa and prolongs on time in patients with Parkinson's disease (PD)
    Barbato, L
    Nordera, G
    Bolner, A
    Caraceni, T
    Stocchi, F
    [J]. MOVEMENT DISORDERS, 2002, 17 : S45 - S45
  • [2] Pharmacokinetic and clinical evaluation of liquid L-dopa/carbidopa in Parkinson's disease
    Marriott, J
    Bryant, B
    Kempster, P
    Shif, M
    Lewis, MM
    Horne, M
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 1998, 5 (02) : 178 - 181
  • [3] Phosphoramidate derivates as controlled-release prodrugs of L-Dopa
    Olatunji, Feyisola
    Kesic, Brittany
    Choy, Cindy
    Berkman, Clifford
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 258
  • [4] Phosphoramidate derivates as controlled-release prodrugs of L-Dopa
    Olatunji, Feyisola P.
    Kesic, Brittany N.
    Choy, Cindy J.
    Berkman, Clifford E.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (18) : 2571 - 2574
  • [5] Peculiarities of L-DOPA treatment of Parkinson’s disease
    R. M. Kostrzewa
    P. Nowak
    J. P. Kostrzewa
    R. A. Kostrzewa
    R. Brus
    [J]. Amino Acids, 2005, 28 : 157 - 164
  • [6] Peculiarities of L-DOPA treatment of Parkinson's disease
    Kostrzewa, RM
    Nowak, P
    Kostrzewa, JP
    Kostrzewa, RA
    Brus, R
    [J]. AMINO ACIDS, 2005, 28 (02) : 157 - 164
  • [7] Cost-utility of pramipexol compared with L-dopa/carbidopa in the treatment of Parkinson's disease in Mexico
    Idrovo, J.
    Rivas, R.
    Zapata, L.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A143 - A143
  • [8] A survival study of Parkinson's disease patients switched to liquid carbidopa/L-dopa
    Janko, KA
    Goetz, C
    Stebbins, G
    [J]. MOVEMENT DISORDERS, 2002, 17 : S92 - S93
  • [9] L-Dopa Pharmacokinetic Profile with Effervescent Melevodopa/Carbidopa versus Standard-Release Levodopa/Carbidopa Tablets in Parkinson's Disease: A Randomised Study
    Stocchi, Fabrizio
    Vacca, Laura
    Grassini, Paola
    Pawsey, Stephen
    Whale, Holly
    Marconi, Stefano
    Torti, Margherita
    [J]. PARKINSONS DISEASE, 2015, 2015
  • [10] Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease
    Descombes, S
    Bonnet, AM
    Gasser, UE
    Thalamas, C
    Dingemanse, J
    Arnulf, I
    Bareille, MP
    Agid, Y
    Rascol, O
    [J]. NEUROLOGY, 2001, 56 (09) : 1239 - 1242
12345